PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Tuberculosis
Related studies linked through entity extraction aliases.
Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis
- Status
- UNKNOWN
- Phase
- PHASE4
Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients
- Status
- COMPLETED
- Phase
- PHASE2
Training Protocol on the Natural History of Tuberculosis
- Status
- RECRUITING
- Phase
- N/A
Study of AERAS-402 in Healthy Infants
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A BCG Challenge Model Study to Assess Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85A
- Status
- COMPLETED
- Phase
- PHASE1
The Incidence and Risk Factors of Side Effects During the Initial Phase of Rifater Therapy - a Prospective Study
- Status
- UNKNOWN
- Phase
- N/A
Safety of Tuberculosis Vaccine, MVA85A, Administered by the Intramuscular Route and the Intradermal Route
- Status
- COMPLETED
- Phase
- PHASE1
The Role of Routine Bacterial Culture Including Tuberculosis During Bronchoscopy: A Prospective Study
- Status
- COMPLETED
- Phase
- N/A
Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Weight and/or Obesity on Dapsone Drug Concentrations
- Status
- COMPLETED
- Phase
- PHASE4
Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis Infection
- Status
- COMPLETED
- Phase
- N/A
Efficacy Against TB Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485)
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
- Status
- COMPLETED
- Phase
- PHASE2
The Impact of Vitamin D on Tuberculosis Among Koreans
- Status
- COMPLETED
- Phase
- N/A
Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis
- Status
- TERMINATED
- Phase
- PHASE2
Treatment Duration for Abdominal Tuberculosis
- Status
- COMPLETED
- Phase
- PHASE3
Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients
- Status
- COMPLETED
- Phase
- N/A